To elucidate the prognostic marker using amino acid PET imaging and signal transduction factors in brain tumor patients
Not Applicable
Recruiting
- Conditions
- brain tumor (glioma)
- Registration Number
- JPRN-UMIN000023933
- Lead Sponsor
- Department of Radiology, Kindai University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
(1)The patient has metastatic brain tumor, malignant lymphoma or other brain tumors and malignant tumors. (2)The glioma patient without treatment adaptation. (3)The document about the agreement with participation of this study is not obtained from patient. (4)Pregnant woman, possibility of the pregnancy woman, lactating woman. (5)The age of the patient is less than 20 age years. (6)The patient cannot undergo PET/CT examination because of serious complication (7)The doctor makes a judgement that the patient is not appropriate for participatingin this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the optimal MET uptake parameter and signal transduction factor for prognosis of glioma patients.
- Secondary Outcome Measures
Name Time Method To reveal whether we predict the expression of signal transduction factors and the degree of malignancy using MET uptake parameters. To investigate whether MET uptake and the expression of signal transduction factors have an influence on the management of therapy such as molecular target therapy in glioma patients. To reveal the relationship between amino acid metabolism and tumorgenesis of glioma using MET uptake, signal transduction factors, and clnicopathological factors.